Idorsia Ltd (IDRSF) Financials

IDRSF Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 573.6 million 2.0 billion
March 31, 2026 599.8 million 2.1 billion
Dec. 31, 2025 587.2 million 2.0 billion
Sept. 30, 2025 570.1 million 2.0 billion

IDRSF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -43.2 million -3.4 million
March 31, 2026 -35.3 million 3.4 million
Dec. 31, 2025 -58.2 million 2.1 million
Sept. 30, 2025 -26.2 million ?

IDRSF Net Income

No data available :(

IDRSF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 109.7 million 1.2 billion 134.4 million
March 31, 2026 118.2 million 1.5 billion 136.6 million
Dec. 31, 2025 110.0 million 1.5 billion 141.4 million
Sept. 30, 2025 89.3 million 1.4 billion 134.8 million

IDRSF Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 316.4 million
March 31, 2026 315.4 million
Dec. 31, 2025 313.0 million
Sept. 30, 2025 269.3 million

IDRSF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 919888 - - -
March 31, 2026 2.0 million 29.6 million 64.2 million -
Dec. 31, 2025 3.6 million 34.7 million 79.8 million -
Sept. 30, 2025 200656 28.3 million 67.5 million -

IDRSF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 65.2 million 18.1 million
March 31, 2026 71.7 million 10.1 million
Dec. 31, 2025 60.5 million 6.6 million
Sept. 30, 2025 52.0 million 12.3 million

IDRSF

Price: $7.31

52 week price:
3.30
8.19

Earnings Per Share: -1.11 USD

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 1.8 billion

Links: